Membership Home Portfolio Stocks Bonds Funds ETFs CEFs Markets Tools Real Life Finance Discuss
Home>Topics>>Takeaways From Teva's Analyst Day: 'Restoring Shareholder Value'

Takeaways From Teva's Analyst Day: 'Restoring Shareholder Value'

Israel Stocks News and Analysis from Seeking Alpha

Thu, 20 Dec 2012

By Logical Assessment : Thesis Following Teva Pharmaceutical's ( TEVA ) Analyst Day , investors were met with a disappointing sell off of roughly 10% within a week, in response to downgrades issued by Leerink Swann and RBC. Teva CEO Jeremy Levin's words appeared to indicate a shift in strategy, ...

Read the rest of this article on Israel Stocks News and Analysis from Seeking Alpha

Content Partners
Site Directory Site Map Our Products
Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News
International Sites: Australia Canada China France Germany Hong Kong Italy The Netherlands Norway Spain U.K. Switzerland India Finland
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.